<p>Final follow-up status by demographic and baseline characteristics of study patients on anti-retroviral therapy (N = 1,321).</p
<p>Determination of timely follow-up CD4 testing by follow-up period in months among patients on ant...
<p>Neg, negative; pos, positive; ART, Anti-retroviral treatment; Pyo, person-years of observation; M...
<p>(a) All available pre-HAART data of CD4 T-cell counts for the cohort of 41 LTNPs since identifica...
<p>Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patie...
<p>Description of follow-up time in years for study patients on anti-retroviral therapy (n = 1,282)....
<p>Determination of timely follow-up CD4 cell count testing by demographic and baseline treatment va...
Comparing baseline characteristics of study participants by antiretroviral therapy status.</p
<p>The group level CD4 cell count as measured by median CD4 cell count at a particular follow-up tim...
<p>Baseline characteristics of patients under TAVI evaluation with complete follow-up data (n = 237 ...
Baseline patient characteristics and completeness of follow-up by treatment arm.</p
<p>The patients’ baseline characteristics before antiviral therapy (n = 196).</p
<p>Socio-demographic and clinical characteristics according to antiretroviral therapy status.</p
Patient and doctor characteristics at baseline, 6-month follow-up (trial endline), and 18-month foll...
<p>Baseline demographic and clinicopathologic characteristics of the 796,335 study patients.</p
Clinical characteristics of patients included in the study based on antiviral treatment.</p
<p>Determination of timely follow-up CD4 testing by follow-up period in months among patients on ant...
<p>Neg, negative; pos, positive; ART, Anti-retroviral treatment; Pyo, person-years of observation; M...
<p>(a) All available pre-HAART data of CD4 T-cell counts for the cohort of 41 LTNPs since identifica...
<p>Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patie...
<p>Description of follow-up time in years for study patients on anti-retroviral therapy (n = 1,282)....
<p>Determination of timely follow-up CD4 cell count testing by demographic and baseline treatment va...
Comparing baseline characteristics of study participants by antiretroviral therapy status.</p
<p>The group level CD4 cell count as measured by median CD4 cell count at a particular follow-up tim...
<p>Baseline characteristics of patients under TAVI evaluation with complete follow-up data (n = 237 ...
Baseline patient characteristics and completeness of follow-up by treatment arm.</p
<p>The patients’ baseline characteristics before antiviral therapy (n = 196).</p
<p>Socio-demographic and clinical characteristics according to antiretroviral therapy status.</p
Patient and doctor characteristics at baseline, 6-month follow-up (trial endline), and 18-month foll...
<p>Baseline demographic and clinicopathologic characteristics of the 796,335 study patients.</p
Clinical characteristics of patients included in the study based on antiviral treatment.</p
<p>Determination of timely follow-up CD4 testing by follow-up period in months among patients on ant...
<p>Neg, negative; pos, positive; ART, Anti-retroviral treatment; Pyo, person-years of observation; M...
<p>(a) All available pre-HAART data of CD4 T-cell counts for the cohort of 41 LTNPs since identifica...
DOI
Add to ORKG